Menu
GeneBe

rs772895065

Variant summary

Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PVS1PM2PP3_StrongPP5

The NM_000137.4(FAH):c.81+2T>A variant causes a splice donor change. The variant allele was found at a frequency of 0.0000048 in 1,457,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000048 ( 0 hom. )

Consequence

FAH
NM_000137.4 splice_donor

Scores

4
2
1
Splicing: ADA: 1.000
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:1

Conservation

PhyloP100: 6.31
Variant links:
Genes affected
FAH (HGNC:3579): (fumarylacetoacetate hydrolase) Predicted to enable fumarylacetoacetase activity. Predicted to be involved in L-phenylalanine catabolic process; homogentisate catabolic process; and tyrosine catabolic process. Predicted to act upstream of or within arginine catabolic process. Located in extracellular exosome. Implicated in tyrosinemia type I. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 15 ACMG points.

PVS1
Splicing variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 15-80153137-T-A is Pathogenic according to our data. Variant chr15-80153137-T-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 402229.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
FAHNM_000137.4 linkuse as main transcriptc.81+2T>A splice_donor_variant ENST00000561421.6
FAHNM_001374377.1 linkuse as main transcriptc.81+2T>A splice_donor_variant
FAHNM_001374380.1 linkuse as main transcriptc.81+2T>A splice_donor_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
FAHENST00000561421.6 linkuse as main transcriptc.81+2T>A splice_donor_variant 1 NM_000137.4 P1P16930-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
250536
Hom.:
0
AF XY:
0.00000738
AC XY:
1
AN XY:
135474
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000265
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000480
AC:
7
AN:
1457870
Hom.:
0
Cov.:
31
AF XY:
0.00000276
AC XY:
2
AN XY:
725364
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000631
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tyrosinemia type I Pathogenic:4Uncertain:1
Likely pathogenic, no assertion criteria providedclinical testingNatera, Inc.Jan 31, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingKnight Diagnostic Laboratories, Oregon Health and Sciences UniversitySep 01, 2015The c.81+2T>A variant in the FAH gene is a novel variant at the canonical splice site and is predicted to affect the splice donor site in intron 1 leading to abnormal splicing. Splice site variants that result in the absence of the FAH enzyme represent a well-established mechanism of disease in tyrosinemia type 1. This variant has not been reported in the 1000 genomes and Exome Sequencing Project control population databases and has been seen at very low frequency in ExAc (0.003%). In addition, splice-site computational algorithms have predicted this variant to abrogate splicing. While we have provisionally classified this variant as likely pathogenic, splicing studies are necessary to confirm this interpretation. To confirm these findings, we recommend submission of another blood specimen from this individual for RNA analysis. Please note that specific collection criteria are required for this sample. For more details and instructions about sample collection (including a specimen collection kit), please contact our laboratory. -
Likely pathogenic, criteria provided, single submitterclinical testingInvitaeDec 22, 2023This sequence change affects a donor splice site in intron 1 of the FAH gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in FAH are known to be pathogenic (PMID: 9101289, 9633815). This variant is present in population databases (rs772895065, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with FAH-related conditions. ClinVar contains an entry for this variant (Variation ID: 402229). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Likely pathogenic, criteria provided, single submitterclinical testingCounsylMay 02, 2017- -
Likely pathogenic, no assertion criteria providedclinical testingBaylor GeneticsSep 30, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.53
D
BayesDel_noAF
Pathogenic
0.21
Cadd
Pathogenic
33
Dann
Uncertain
0.99
Eigen
Pathogenic
0.94
Eigen_PC
Pathogenic
0.76
FATHMM_MKL
Uncertain
0.91
D
MutationTaster
Benign
1.0
D;D;D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.93
SpliceAI score (max)
0.98
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.98
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs772895065; hg19: chr15-80445479; API